BioImagene
acquires TissueInformatics Inc, and strengthens
its position as the leader in integrated solutions
for Tox-Path.
Cupertino, Calif.— June 15, 2006 -- BioImagene
announced today the closing of its acquisition of
TissueInformatics, from Icoria - a business unit
of Clinical Data Inc.
This acquisition makes BioImagene the technological
leader in tissue analysis and enriches their product
portfolio from research to Tox-path.
TissueInformatics is a pioneering company in tissue
image analysis, based in Pittsburgh Pennsylvania.
It specializes in the development and application
of automated pathology software for the quantitative
analysis of tissue changes in drug discovery, disease
assessment, toxicology, and tissue engineering research.
BioImagene has taken a key step in their growth strategy
with the acquisition of TissueInformatics; namely:
• The synergies bring with it a broad pipeline
of IP-protected product opportunities and innovations
in the tox-path area;
• Stronger East Coast presence serves the growing
needs of Bio-Tech and pharmaceutical companies;
• Merger of the core strengths in tissue-image
analysis with data and Image management and mining
solutions addresses
significant unmet needs in the tox-path market;
• Customers and partners can leverage BioImagene’s
strong resources for new and continuing projects.
The combined company plans to rapidly integrate TissueInformatics
core technology
into the BioImagene platform and application suite.
Mr Mohan Uttarwar, CEO of BioImagene said, “ This
acquisition meets our key business objective of accelerating
our efforts in the Tox-path market by offering a
comprehensive solution. We welcome TissueInformatics
expertise in automated toxpath solutions and deep
scientific understanding of tissue morphology.”
The present TissueInformatics management team will
spearhead BioImagene’s presence on the East
coast and will maintain its presence in Pittsburgh,
Pennsylvania. Max Fedor of TissueInformatics will
join the BioImagene team as the Vice-president of
Business Development.
TSG partners acted as advisers to BioImagene in the
acquisition process. TSG Partners is a specialty
advisory group focused on developing sector leaders
in life sciences.
About TissueInformatics
TissueInformatics has pioneered automation of analysis
of normal and pathological tissue. It has revolutionized
the tissue analysis process by enabling automated
quantitative analysis of tissues and has developed
industry-wide expertise in tissue image capture,
analysis and tissue morphology.
About BioImagene, Inc
BioImagene provides sophisticated Bio-Image Analysis & Management
products built on their technology platforms SIMS™ & iHARNESS™.
BioImagene’s products allow researchers to
effectively manage and analyze large numbers of large-sized
images and their associated metadata. Image and numerical
data can be easily shared across the web, facilitating
collaboration and accelerating decision-making. Their
customers include the top pharmaceutical and biotech
companies as well as major pathology research laboratories.
BioImagene is headquartered in Cupertino, California.
For more information please visit www.bioimagene.com.
For details on the acquisition please contact Ms
Gauri Naik , Director Marketing, BioImagene Inc.
at 1 408 914 2619
